Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12623000936628p
Ethics application status
Submitted, not yet approved
Date submitted
4/08/2023
Date registered
30/08/2023
Date last updated
30/08/2023
Date data sharing statement initially provided
30/08/2023
Type of registration
Prospectively registered
Titles & IDs
Public title
Self-administered inhaled methoxyflurane (Penthrox®) as pre-injection analgesia in Podiatry Outpatients
Query!
Scientific title
Efficacy of self-administered inhaled methoxyflurane (Penthrox®) as pre-injection analgesia in Podiatry Outpatients
Query!
Secondary ID [1]
310261
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
pain
330941
0
Query!
Condition category
Condition code
Anaesthesiology
327748
327748
0
0
Query!
Pain management
Query!
Public Health
327993
327993
0
0
Query!
Health service research
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Self-administered inhaled methoxyflurane (via a hand-held Penthrox inhaler) as pre-injection analgesia.
Once off dose: 3mL methoxyflurane 99.9% inhalation solution.
Participants will be instructed to inhale and exhale through the mouthpiece of the inhaler. If a higher concentration of analgesia is required, the participant will be instructed to occlude the diluter hole with their finger.
Duration: The participant will be instructed to take 6 slow breaths through the inhaler before the local anaesthetic is administered. The participant may then take additional breaths as required while the local anaesthetic is being administered. (Approx 5 minutes). Once the local anaesthetic has been administered, the inhaler will be removed from the participant and disposed of accordingly. The participant will be closely monitored by a Registered Nurse who record observations including oxygen saturation, heart rate, respiratory rate, sedation score, adverse events and ensure the inhaler is used as instructed.
Query!
Intervention code [1]
326664
0
Treatment: Drugs
Query!
Comparator / control treatment
placebo inhaler. This will take the form of a Penthrox inhaler where no methoxyflurane has been decanted into it. Instead 3 drops of methoxyflurane will be added to the wrist strap to give a similar smell to the intervention inhaler.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
335639
0
Verbal Numerical Pain Rating Score (VNPRS) (10-point scale from 0 to 10, where 0 is no pain at all and 10 is worst pain imaginable).
Query!
Assessment method [1]
335639
0
Query!
Timepoint [1]
335639
0
Baseline and worst pain experienced during the procedure (includes local anaesthetic administration and toenail surgery). The second timepoint will be asked 1.25 hours following the procedure to allow the effects of the methoxyflurane to wear off as to not impact on the participant's cognition.
Query!
Secondary outcome [1]
425027
0
Verbal Numerical Anxiety Rating Score (VNARS) (10-point scale from 0-10, where 0 is no anxiety and 10 is extreme anxiety).
Query!
Assessment method [1]
425027
0
Query!
Timepoint [1]
425027
0
Baseline, and immediately following administration of local anaesthetic.
Query!
Secondary outcome [2]
425028
0
patient satisfaction (7-point Likert scale from ‘extremely dissatisfied’ to ‘extremely satisfied’)
Query!
Assessment method [2]
425028
0
Query!
Timepoint [2]
425028
0
1.25 hours following the procedure to allow the effects of the methoxyflurane to wear off.
Query!
Eligibility
Key inclusion criteria
o 18 years of age and over
o A painful ingrown toenail which requires a minor surgical procedure
o Ability to self-administer methoxyflurane via a hand-held Penthrox® inhaler.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
o A documented history of cognitive impairment or are otherwise unable to give informed consent
o Allergy to methoxyflurane or any other medication or agent required for the procedure
o A personal or familial history of malignant hyperthermia
o Previous history of a significant head injury
o Significant renal impairment (eGFR<60mL/min)
o Significant cardiac or respiratory illnesses
o Women who are pregnant, planning to become pregnant or breastfeeding
o Patients taking concurrent drugs with known clinically significant nephrotoxic effects (patients taking tetracyclines, aminoglycosides, colistin, amphotericin B, barbiturates, alcohol, isoniazid and rifampicin will be excluded).
o Alcohol consumption in the 24 hours prior to the procedure
o Patients who have received methoxyflurane on the day prior to the procedure or 15 mL (5 bottles) in the week prior to the procedure.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
central randomisation by computer
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A sample size calculation has been performed based on a mean difference of three increments on the VNPRS (justified on the basis that methoxyflurane is likely to be more effective in this study than for trauma where a difference of 1.5 was found (Coffey et al., 2014)), and a standard deviation of 3/10 (Cohen et al., 2022), results in a sample size of 40 participants required in total (20 in each arm) accounting for drop-out of no more than 10%.
• The two groups will be compared statistically at baseline using the Fisher’s exact test. The Wilcoxon rank-sum test will be used for non-normally distributed continuous variables and the independent student’s t-test will be used for normally distributed continuous variables.
• The distribution of the primary outcome measure VNPRS (as reported in the survey one hour post procedure) will be assessed using visual inspection of plotted data and a Shapiro-Wilk test for normality. If an assumption of normally distributed pain scores is reasonable based on our observed data, then an independent student’s t-test will be used to compare the two groups. If the assumption of normality isn’t met, simple transformations will be used to achieve normality, proceeding as above if normality is achieved. If despite these transformations, normality of distribution cannot be assumed, then the pain scores will be categorised into no/mild pain (0-3), moderate pain (4-7), and severe pain (8-10), and we will utilise ordinal (if a proportional hazard assumption is valid) or multinomial regression (if the proportional hazard assumption is invalid) analysis.
• Secondary outcomes of anxiety reduction and user satisfaction will be compared between the two groups as described below.
• VNARS will be compared across the two time points (baseline versus immediately following procedure) using a t-test or Kruskall Wallis rank-sum test.
• Ordinal or multinomial regression will be used to assess differences in the proportion of patients who report being ‘very’ or ‘extremely’ satisfied with the procedure experience between groups. Convenience ratings will be assessed the same way.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/09/2023
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Funding & Sponsors
Funding source category [1]
314469
0
Charities/Societies/Foundations
Query!
Name [1]
314469
0
Flinders Foundation
Query!
Address [1]
314469
0
Flinders Drive, Bedford Park SA 5042
Query!
Country [1]
314469
0
Australia
Query!
Funding source category [2]
314509
0
Charities/Societies/Foundations
Query!
Name [2]
314509
0
The Hospital Research Foundation Group
Query!
Address [2]
314509
0
PO Box 77, Woodville SA 5011
Query!
Country [2]
314509
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Claire Huxtable
Query!
Address
Noarlunga Health Service
30 Alexander Kelly Drive, Noarlunga Centre SA 5168
Query!
Country
Australia
Query!
Secondary sponsor category [1]
316454
0
Government body
Query!
Name [1]
316454
0
Southern Adelaide Local Health Network
Query!
Address [1]
316454
0
Noarlunga Health Service
30 Alexander Kelly Drive, Noarlunga Centre SA 5168
Query!
Country [1]
316454
0
Australia
Query!
Secondary sponsor category [2]
316455
0
University
Query!
Name [2]
316455
0
UniSA
Query!
Address [2]
316455
0
City East University of South Australia GPO Box 2471. Adelaide SA 5001
Query!
Country [2]
316455
0
Australia
Query!
Ethics approval
Ethics application status
Submitted, not yet approved
Query!
Ethics committee name [1]
313520
0
Southern Adelaide Clinical Human Research Ethics Committee
Query!
Ethics committee address [1]
313520
0
Flinders Medical Centre
Flinders Drive, Bedford Park SA 5042
Query!
Ethics committee country [1]
313520
0
Australia
Query!
Date submitted for ethics approval [1]
313520
0
19/05/2023
Query!
Approval date [1]
313520
0
Query!
Ethics approval number [1]
313520
0
Query!
Ethics committee name [2]
313552
0
UniSA Human Research Ethics Committee
Query!
Ethics committee address [2]
313552
0
City East University of South Australia GPO Box 2471. Adelaide SA 5001
Query!
Ethics committee country [2]
313552
0
Australia
Query!
Date submitted for ethics approval [2]
313552
0
18/08/2023
Query!
Approval date [2]
313552
0
Query!
Ethics approval number [2]
313552
0
Query!
Summary
Brief summary
Ingrown toenails are a common presentation to any podiatry setting (Borges et al., 2017; Khunger & Kandhari, 2012). Although the true prevalence of this condition is difficult to determine, it has been reported to occur in approximately 2.5-5% of the population (Vural et al., 2018). Treatment often involves surgical excision using a local anaesthetic digital ring block (most commonly using plain lidocaine) (Eekhof et al., 2012). These injections can be a source of pain and anxiety for patients. If patients have a severe needle phobia, they are often referred to have the procedure conducted in theatre under a general anaesthetic. Hundreds of South Australians are currently on the public elective surgery waiting list for this procedure, the majority of which are triaged as a Category 3 with a recommended waiting time of within 365 days (Australian Institute of Health and Welfare, 2023). These patients risk prolonged infection, pain, and deterioration of their condition, which can place unnecessary emotional and economic burden on the patient, and the health care system (Oudhoff et al., 2007).
SA Health, as the provider of public health in South Australia, have recently approved the use of inhaled methoxyflurane by Podiatrists who meet prescribing requirements. The use of methoxyflurane for podiatric surgical procedures can provide a lower risk and more timely alternative for patients with a needle phobia to receive care without the need for general anaesthesia (Jephcott et al., 2018). In this situation, methoxyflurane can be used as an analgesic prior to and during the local anaesthetic injections enabling many more patients to have their procedure performed in outpatient (OPD) clinics. In addition to improving patient outcomes, this could reduce elective surgical waiting lists and the demand for surgical services, reducing the overall cost that these procedures would otherwise have on the health care system.
Hypothesis: Is self-administered, inhaled methoxyflurane (Penthrox®) effective in reducing pain during local anaesthetic administration in a Podiatry Outpatient setting?
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
128426
0
Ms Claire Huxtable
Query!
Address
128426
0
Noarlunga Health Service
30 Alexander Kelly Drive, Noarlunga Centre SA 5168
Query!
Country
128426
0
Australia
Query!
Phone
128426
0
+61430520109
Query!
Fax
128426
0
Query!
Email
128426
0
[email protected]
Query!
Contact person for public queries
Name
128427
0
Ms Claire Huxtable
Query!
Address
128427
0
Noarlunga Health Service
30 Alexander Kelly Drive, Noarlunga Centre SA 5168
Query!
Country
128427
0
Australia
Query!
Phone
128427
0
+61430520109
Query!
Fax
128427
0
Query!
Email
128427
0
[email protected]
Query!
Contact person for scientific queries
Name
128428
0
Ms Claire Huxtable
Query!
Address
128428
0
Noarlunga Health Service
30 Alexander Kelly Drive, Noarlunga Centre SA 5168
Query!
Country
128428
0
Australia
Query!
Phone
128428
0
+61430520109
Query!
Fax
128428
0
Query!
Email
128428
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF